Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1720 (LINC01720) is a non-protein coding RNA gene classified as a long intergenic non-coding RNA (lincRNA)[1][3][5][7]. LincRNAs are sequences of RNA longer than 200 nucleotides that do not overlap protein-coding genes and generally do not code for proteins[5][7]. Their functions are diverse and include regulation of gene expression, chromatin remodeling, and RNA stabilization, but most have not been specifically characterized. There is currently no evidence that LINC01720 is a validated therapeutic target, implicated in specific diseases, or interacts with any drugs. No data suggest its use as a biomarker or indicate safety considerations in a therapeutic context. The information available is limited to its bioinformatic annotation as a lincRNA, and further functional research would be required to clarify any biological or clinical significance[1][3][5][7].
Not applicable / none known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1720 (LINC01720).